Hitachi Global Life Solutions (CGT)

Yokohama, Japan

Profile last updated: 2026-07-02

Hybrid — also manufactures internal programs

Cell Therapy CAR-T

No confirmed program data — ClinicalTrials.gov verification pending · Last scored 2026-09-07

63.0

Signal Score

○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Hitachi Global Life Solutions (CGT)

Signal Score: 63.0/100 (as of 2026-09-07)
Quality Compliance: Assessment pending
Headquarters: Yokohama, Japan
Modalities: Cell Therapy, CAR-T
Active Programs: Data pending
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By: CDMO Signal — independent CDMO intelligence platform

About Hitachi Global Life Solutions (CGT)

Hybrid developer + CDMO.

Signal Score & Pillar Breakdown

Scores are being republished. Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.

Quality Compliance —

No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.

FDA InspectionsNo US records on file

Operations —

No ClinicalTrials.gov facility matches confirmed for this manufacturer.

Programs — no verified data

Sponsors— no verified data

ModalitiesCell Therapy, CAR-T

Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.

Financial Stability

Profile-based financial assessment

SEC FilingsPrivate company

Capacity

Profile-based capacity assessment

Frequently Asked Questions About Hitachi Global Life Solutions (CGT)

What is Hitachi Global Life Solutions (CGT)'s CDMO Signal Score?

Hitachi Global Life Solutions (CGT) has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.

Evaluating Hitachi Global Life Solutions (CGT) for a manufacturing program?

Use the free AI matchmaker to compare Hitachi Global Life Solutions (CGT) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.

Find & compare CDMOs →

Represent this organization? Contact us to verify or update this profile.

See all CDMOs in:

Cell Therapy CDMOs → CAR-T CDMOs →